Among them, TP53 mutations, frequently found in chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and diffuse large B-cell lymphoma (DLBCL), are associated with chemo-refractoriness, rapid progression, and significantly reduced survival. The gene discussed is TP53; the disease is diffuse large B-cell lymphoma.